Risk Factors for Hepatotoxicity in Patients Treated With Highly Active Antiretroviral Therapy
- 1 July 2001
- journal article
- letter
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 27 (3) , 316-318
- https://doi.org/10.1097/00126334-200107010-00017
Abstract
An abstract is unavailable. This article is available as a PDF only.This publication has 4 references indexed in Scilit:
- Risk Factors for Hepatotoxicity in HIV-1--Infected Patients Receiving Ritonavir and Saquinavir with or without StavudineClinical Infectious Diseases, 2000
- Incidence of Adverse Reactions in HIV Patients Treated With Protease Inhibitors: A Cohort StudyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Hepatotoxicity Associated With Antiretroviral Therapy in Adults Infected With Human Immunodeficiency Virus and the Role of Hepatitis C or B Virus InfectionJAMA, 2000
- Severe hepatic cytolysis: incidence and risk factors in patients treated by antiretroviral combinations Aquitaine Cohort, France, 1996-1998AIDS, 1999